The Comprehensive 2024 Gastroenterology Update

This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.

Highlights of the 2024 program include:

Practical, Results-Driven Education

• Updated guidelines for the use of biologics in IBD
• Therapeutic drug monitoring in IBD treatment
• Management of the older adult with IBD
• Updated guidelines for treatment of  infection

C. difficile

• Managing GI complications of immunotherapy
• Improved management of IBS
• Tips to managing fecal incontinence
• Management of refractory GERD
• Expanded genetic testing options to diagnose hereditary GI cancer syndromes
• Management of fatty liver disease in 2024
• How to diagnose and manage cirrhosis
• How to improve your adenoma detection rate (ADR)
• Steps to ensure delivery of high-quality colonoscopic care
• Techniques to effectively control acute GI bleeding
• Endoscopic management of obesity
• When FMT is indicated for treatment
• Impact of COVID on the GI tract
• New strategies to treat common GI problems
• A comprehensive update of national guidelines

As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

The evidence-based recommendations provided in this program cover:

Education to Optimize Your Patient Outcomes

• IBD
• GI Complications of Immunotherapy
• Microscopic Colitis
• Fatty Liver
• Barrett’s Esophagus
• Eosinophilic Esophagitis
•  Colitis

C. difficile

• Alcohol-Related Liver Disease
• Autoimmune Hepatitis
• IBS
• Refractory GERD
• Acute Pancreatitis
• Chronic Pancreatitis
• Celiac Disease
• GI Bleeding
• High Risk for Colorectal Cancer

Clinicians can rely on this program for education on:

Recent Advances and Innovations

• Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
• Managing refractory pouchitis
• GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
• Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
• The stool microbiome: understanding the science behind clinical applications
• Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
• Adenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate
• Endoscopic approaches to managing obesity

This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.

Who Should Attend

• Gastroenterologists
• Internists
• Surgeons
• Nurse Practitioners
• Physician Assistants